These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8846684)

  • 21. [Determination of fasting blood glucose and serum fructosamine levels for the assessment of glucose regulation in patients with non-insulin dependent diabetes mellitus].
    van Haeften TW; Walstra SM; Rustemeijer C
    Ned Tijdschr Geneeskd; 1989 Nov; 133(47):2356-7. PubMed ID: 2586671
    [No Abstract]   [Full Text] [Related]  

  • 22. Goals and assessment of diabetic control.
    Scott DJ; Cooper GJ
    N Z Med J; 1985 Jul; 98(782):536-8. PubMed ID: 3897925
    [No Abstract]   [Full Text] [Related]  

  • 23. Fructosamine: an alternative assessment of past glycaemic control in developing countries.
    Islam N; Akhter J; Kayani N; Khan MA
    J Pak Med Assoc; 1993 Nov; 43(11):238-40. PubMed ID: 8114262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical usefulness of serum fructosamine and HbAlc in patients with NIDDM.
    Lim SY; Jhoo YM; Lee SS; Lee MH; Chung ES; Lee SJ
    Korean J Intern Med; 1989 Jul; 4(2):155-9. PubMed ID: 2486845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Levels of fasting blood glucose and serum fructosamine for monitoring of glucose control in patients with non-insulin-dependent diabetes mellitus].
    Mercelina LF; Degenaar CP; Nieuwenhuijzen Kruseman AC
    Ned Tijdschr Geneeskd; 1989 Sep; 133(38):1887-90. PubMed ID: 2797305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Home blood glucose monitoring, glycosylated hemoglobin and fructosamine: their relationships in diabetic patients with and without residual C-peptide secretion.
    Brichard SM; van den Abbeele E; Ketelslegers JM; Lambert AE
    Diabete Metab; 1989; 15(6):388-93. PubMed ID: 2628041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Critical evaluation of fructosamine as a control parameter in the assessment of diabetic metabolic regulation].
    Hay U; Sedlmayer A; Müller MM; Dorda W; Schernthaner G
    Klin Wochenschr; 1989 Apr; 67(7):379-85. PubMed ID: 2747138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood glycated haemoglobin, serum fructosamine, serum glycated albumin and serum glycated total protein as measures of glycaemia in diabetes mellitus.
    Koskinen P; Erkkola R; Viikari J; Mattila K; Irjala K
    Scand J Clin Lab Invest; 1992 Dec; 52(8):863-9. PubMed ID: 1488624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of fructosamine with glycosylated hemoglobin and plasma proteins as measures of glycemic control.
    Smart LM; Howie AF; Young RJ; Walker SW; Clarke BF; Smith AF
    Diabetes Care; 1988 May; 11(5):433-6. PubMed ID: 3391095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the measurement of serum fructosamine accurately reflect levels of glycated albumin in insulin-dependent diabetes?
    Winocour PH; Bhatnagar D; Reed P; Dhar H
    Ann Clin Biochem; 1987 Jan; 24 ( Pt 1)():47-52. PubMed ID: 3827184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical chemical parameters for metabolic control of patients with diabetes mellitus].
    Sindrup SH; Matzen LE; Wengler K; Frøland A; Reinholdt B
    Nord Med; 1989; 104(2):50-1, 53. PubMed ID: 2919156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fructosamine and glycated haemoglobin in the assessment of long term glycaemic control in diabetes.
    Shield JP; Poyser K; Hunt L; Pennock CA
    Arch Dis Child; 1994 Nov; 71(5):443-5. PubMed ID: 7826117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of fructosamine, glycosylated hemoglobin and glucose in patients with type II diabetes].
    Tvorogova MG; Zaĭtseva TM; Aronskaia EE; Kozlov SG; Sharipova GKh; Titov VN
    Klin Lab Diagn; 1995; (1):10-2. PubMed ID: 7757352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased sialidase activity in mononuclear leucocytes of type 1 diabetic subjects: relationship to diabetic complications and glycaemic control.
    Waters PJ; Flynn MD; Pennock CA; Corrall RJ; Greenwood RJ; Eisenthal R
    Diabet Med; 1995 Aug; 12(8):670-3. PubMed ID: 7587004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical validity of a self-test fructosamine in outpatient diabetic management.
    Cefalu WT; Wang ZQ; Redmon E; Bell-Farrow AD; McBride D; King T
    Diabetes Technol Ther; 1999; 1(4):435-41. PubMed ID: 11474829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Routine control of type 2 diabetes. Are glycosylated hemoglobin and fructosamine measurements necessary?].
    Tryggeseth A
    Tidsskr Nor Laegeforen; 1990 Aug; 110(19):2539-40. PubMed ID: 2219017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma protein glycation as measured by fructosamine assay.
    Mosca A; Carenini A; Zoppi F; Carpinelli A; Banfi G; Ceriotti F; Bonini P; Pozza G
    Clin Chem; 1987 Jul; 33(7):1141-6. PubMed ID: 3594841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of serum fructosamine in the metabolic control of children and adolescents with type I diabetes mellitus].
    Krause M; Pfüller H; Herbst D; Kruse K
    Monatsschr Kinderheilkd; 1987 Apr; 135(4):200-3. PubMed ID: 3600671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control.
    Wörner W; Pfleiderer S; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort.
    Malmström H; Walldius G; Grill V; Jungner I; Gudbjörnsdottir S; Hammar N
    PLoS One; 2014; 9(10):e111463. PubMed ID: 25353659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.